Atlas Trials

Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

Clinical trial NCT03146403 · TERMINATED

Trial details

NCT number
NCT03146403
Sponsor
Genocea Biosciences, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Genital HerpesHSV-2 Infection
Start date
2017-05-24
Primary completion
2017-12-22
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.